• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY TRANSHEPATIC; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY TRANSHEPATIC; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00574650
Medical Device Problem Codes Adverse Event Without Identified Device or Use Problem (2993); Migration (4003)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/21/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the stent externalized following deployment.The target lesion was located in the mildly tortuous and mildly calcified vessel.An 8mmx100mm wallflex biliary transhepatic was advanced for treatment.During the procedure, the stent externalized following deployment.It came out when the delivery system was being removed.The procedure was completed using an alternative method.No complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: the stent was returned fully expanded and deployed.Additionally, the outer sheath was returned kinked.Based on the analysis of the returned product, the reported allegation of stent migration could not be confirmed, because it happened during the procedure.
 
Event or Problem Description
It was reported that the stent externalized following deployment.The target lesion was located in the mildly tortuous and mildly calcified vessel.An 8mmx100mm wallflex biliary transhepatic was advanced for treatment.During the procedure, the stent externalized following deployment.It came out when the delivery system was being removed.The procedure was completed using an alternative method.No complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX BILIARY TRANSHEPATIC
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key20707130
Report Number2124215-2024-71613
Device Sequence Number20845966
Product Code FGE
UDI-Device Identifier08714729799436
UDI-Public08714729799436
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K112543
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/31/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/25/2025
Device Model NumberM00574650
Device Catalogue NumberM00574650
Device Lot Number0032925631
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/23/2024
Supplement Date Received by Manufacturer01/15/2025
Initial Report FDA Received Date11/18/2024
Supplement Report FDA Received Date01/31/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/26/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-